TC
Congress trade
Sen. Thomas Carper (D-DE) bought $1K-$15K of Tekla Life Sciences Investors (HQL) stock
Thomas Carper, U.S. Senator (D-DE), disclosed a purchase of Tekla Life Sciences Investors (HQL) stock worth $1K-$15K in a STOCK Act filing on Mar 3, 2020.
The trade happened on Feb 22, 2020, 10 days before it was made public.
- Traded
- Feb 22, 2020
- Disclosed
- Mar 3, 2020
- Filing delay
- 10 days
- Source
- STOCK Act disclosure
Other trades in this disclosure (3)
More HQL insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.